|
2016 Journal Article Mapping time-course mitochondrial adaptations in the kidney in experimental diabetesCoughlan, Melinda T., Nguyen, Tuong-Vi, Penfold, Sally A., Higgins, Gavin C., Thallas-Bonke, Vicki, Tan, Sih Min, Van Bergen, Nicole J., Sourris, Karly C., Harcourt, Brooke E., Thorburn, David R., Trounce, Ian A., Cooper, Mark E. and Forbes, Josephine M. (2016). Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes. Clinical Science, 130 (9), 711-720. doi: 10.1042/CS20150838 |
|
2016 Journal Article Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trialRossi, Megan, Johnson, David W., Morrison, Mark, Pascoe, Elaine M., Coombes, Jeff S., Forbes, Josephine M., Szeto, Cheuk-Chun, McWhinney, Brett C., Ungerer, Jacobus P. J. and Campbell, Katrina L. (2016). Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clinical Journal of the American Society of Nephrology, 11 (2), 223-231. doi: 10.2215/CJN.05240515 |
|
2016 Journal Article Tapping into mitochondria to find novel targets for diabetes complicationsFleming, Nicole B., Gallo, Linda, Ward, Micheal S. and Forbes, Josephine M. (2016). Tapping into mitochondria to find novel targets for diabetes complications. Current Drug Targets, 17 (12), 1341-1349. doi: 10.2174/1389450116666150727114410 |
|
2015 Journal Article Abdominal obesity and brain atrophy in type 2 diabetes mellitusClimie, Rachel E. D., Moran, Chris, Callisaya, Michele, Blizzard, Leigh, Sharman, James E., Venn, Alison, Phan, Thanh G., Beare, Richard, Forbes, Josephine, Blackburn, Nicholas B. and Srikanth, Velandai (2015). Abdominal obesity and brain atrophy in type 2 diabetes mellitus. PloS One, 10 (11) e0142589, e0142589. doi: 10.1371/journal.pone.0142589 |
|
2015 Conference Publication IL-22-mediated suppression of islet inflammationMcGuckin, Mike, Hasnain, Sumaira Z., Borg, Danielle J., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathon P., Forbes, Josephine M. and Prins, John B. (2015). IL-22-mediated suppression of islet inflammation. IPITA/IXA/CTS Joint Congress, Melbourne Australia, Nov 15-19, 2015. HOBOKEN: LIPPINCOTT WILLIAMS & WILKINS. |
|
2015 Conference Publication Human soluble receptor for advanced glycation end products therapy reduces autoimmune diabetes in the non-obese diabetic mouseLeung, S. S.-Y., Borg, D. J., McCarthy, D., Zhuang, A., Fotheringham, A., Di Trapani, G., Groop, P.-H., Knip, M. and Forbes, J. (2015). Human soluble receptor for advanced glycation end products therapy reduces autoimmune diabetes in the non-obese diabetic mouse. Joint Annual Conference of the International Society for Pediatric and Adolescent Diabetes and Australasian Paediatric Endocrine Group (ISPAD+APEG 2015), Brisbane, QLD Australia, 7-10 October 2015. Hoboken, NJ USA: Wiley-Blackwell Publishing. doi: 10.1111/pedi.12309 |
|
2015 Conference Publication Gene Therapy Using Recombinant Adeno-Associated Virus Serotype 2/8 Liver-Directed Expression of Srage in Experimental Type 1 DiabetesLeung, Sherman S., Borg, Danielle J., Paul, Moumita, Sharland, Alexandra F. and Forbes, Josephine M. (2015). Gene Therapy Using Recombinant Adeno-Associated Virus Serotype 2/8 Liver-Directed Expression of Srage in Experimental Type 1 Diabetes. 9th Biennial Meeting of the Australasian-Gene-and-Cell-Therapy-Society (AGCTS), Parkville, VIC Australia, 29 April - 1 May 2015. Hoboken, NJ United States: Wiley-Blackwell. |
|
2015 Journal Article Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: a study protocol for a double-blind, randomized, two period cross-over trialde Courten, Barbora, de Courten, Maximilian P. J., Schalkwijk, Casper G., Walker, Karen Z. and Forbes, Josephine (2015). Dietary advanced glycation end products consumption as a direct modulator of insulin sensitivity in overweight humans: a study protocol for a double-blind, randomized, two period cross-over trial. JMIR Research Protocols, 4 (3) e93, e93+. doi: 10.2196/resprot.4552 |
|
2015 Conference Publication Recombinant human soluble receptor for advanced glycation end product therapy reduces autoimmune diabetes in the NOD mouse modelLeung, Sherman, Borg, Danielle J., McCarthy, Domenica, Zhuang, Aowen, Forbes, Josephine and Ward, Micheal (2015). Recombinant human soluble receptor for advanced glycation end product therapy reduces autoimmune diabetes in the NOD mouse model. 75th Scientific Sessions of the American-Diabetes-Association, Boston, MA United States, 5-9 June 2015. Alexandria, VA United States: American Diabetes Association. |
|
2015 Conference Publication Synbiotic therapy in pre-dialysis: a randomised controlled trialRossi, Megan, Johnson, David, Pascoe, Elaine, Coombes, Jeff, Forbes, Josephine, Szeto, Cheuk-Chun, McWhinney, Brett, Ungerer, Jacobus and Campbell, Katrina (2015). Synbiotic therapy in pre-dialysis: a randomised controlled trial. 52nd ERA-EDTA Congress, London, United Kingdom, 28-31 May 2015. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv152.02 |
|
2015 Journal Article Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetesSalonen, Kirsi M., Ryhanen, Samppa J., Forbes, Josephine M., Borg, Danielle J., Harkonen, Taina, Ilonen, Jorma, Simell, Olli, Veijola, Riitta, Groop, Per-Henrik and Knip, Mikael (2015). Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes. Diabetes Care, 38 (4), 665-670. doi: 10.2337/dc14-1186 |
|
2015 Journal Article A rapid extraction method for glycogen from formalin-fixed liverSullivan, Mitchell A., Li, Shihan, Aroney, Samuel T.N., Deng, Bin, Li, Cheng, Roura, Eugeni, Schulz, Benjamin L., Harcourt, Brooke E., Forbes, Josephine M. and Gilbert, Robert G. (2015). A rapid extraction method for glycogen from formalin-fixed liver. Carbohydrate Polymers, 118, 9-15. doi: 10.1016/j.carbpol.2014.11.005 |
|
2015 Conference Publication In Db/db mice, Sglt2 inhibition does not improve diabetic nephropathy despite glycaemic improvementsGallo, L. A., Ward, M. S., Fotheringham, A. K., Pollock, C., Panchapakesan, U. and Forbes, J. M. (2015). In Db/db mice, Sglt2 inhibition does not improve diabetic nephropathy despite glycaemic improvements. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543 |
|
2015 Conference Publication IL-22-MEDIATED SUPPRESSION OF ISLET INFLAMMATIONMcGuckin, Mike, Hasnain, Sumaira Z., Borg, Danielle J., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathon P., Forbes, Josephine M. and Prins, John B. (2015). IL-22-MEDIATED SUPPRESSION OF ISLET INFLAMMATION. Joint Congress of the International-Pancreas-and-Islet-Transplantation-Association, International-Xenotransplantation-Association and Cell-Transplant-Society, Melbourne Australia, Nov 15-19, 2015. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2015 Book Chapter Pathogenesis of diabetic microvascular complicationsForbes, Josephine M. and Harcourt, Brooke (2015). Pathogenesis of diabetic microvascular complications. International Textbook of Diabetes Mellitus. (pp. 873-888) wiley. doi: 10.1002/9781118387658.ch60 |
|
2015 Journal Article Impairment of liver glycogen storage in the db/db animal model of type 2 diabetes: a potential target for future therapeutics?Sullivan, Mitchell A., Harcourt, Brooke E., Xu, Ping, Forbes, Josephine M. and Gilbert, Robert G. (2015). Impairment of liver glycogen storage in the db/db animal model of type 2 diabetes: a potential target for future therapeutics?. Current Drug Targets, 16 (10), 1088-1093. doi: 10.2174/1389450116666150727123115 |
|
2015 Conference Publication Synbiotic Therapy in Pre-Dialysis: a Randomised Controlled TrialRossi, Megan, Johnson, David, Pascoe, Elaine, Coombes, Jeff, Forbes, Josephine, Szeto, Cheuk-Chun, McWhinney, Brett, Ungerer, Jacobus and Campbell, Katrina (2015). Synbiotic Therapy in Pre-Dialysis: a Randomised Controlled Trial. 52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London England, 28-31 May 2015. United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfv152.2 |
|
2015 Journal Article Type 2 diabetes, skin autofluorescence, and brain atrophyMoran, C., Munch, G., Forbes, J.M., Beare, R., Blizzard, L., Venn, A.J., Phan, T.G., Chen, J. and Srikanth, V. (2015). Type 2 diabetes, skin autofluorescence, and brain atrophy. Diabetes, 64 (1), 279-283. doi: 10.2337/db14-0506 |
|
2015 Conference Publication Short-term alagebrium chloride (ALT-711) therapy pre-diabetes for the treatment of Type I DiabetesBorg, D. J., McCarthy, D., Reeves, P., Ward, M. S., Fotheringham, A. K., Gallo, L. A., Harcourt, B. E., Agrawal, N., Steptoe, R. and Forbes, J. M. (2015). Short-term alagebrium chloride (ALT-711) therapy pre-diabetes for the treatment of Type I Diabetes. Immunology of Diabetes Society 14th International Congress, Munich, Germany, 12-16 April 2015. |
|
2015 Conference Publication Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse modelBorg, D. J., Leung, S., Zhuang, A., Fotheringham, A., McCarthy, D., Di Trapani, J., Groop, P. -H., Knip, M. and Forbes, J. (2015). Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse model. 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, Sweden, 14-18 September 2015. Heidelberg, Germany: Springer. doi: 10.1007/s00125-015-3687-4 |
